This webinar will address the ongoing challenges and advancements in overcoming endocrine resistance in metastatic breast cancer (MBC). Experts will discuss the latest developments in targeted therapies, clinical strategies for managing resistance across treatment lines, and the role of biomarker testing in optimizing patient outcomes. The session aims to provide valuable insights into current treatment approaches and emerging trends in MBC management.